Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Cancer chemotherapy and pharmacology

Results: 1-25/223

Authors: HERMAN EH ZHANG J FERRANS VJ
Citation: Eh. Herman et al., COMPARISON OF THE PROTECTIVE EFFECTS OF DESFERRIOXAMINE AND ICRF-187 AGAINST DOXORUBICIN-INDUCED TOXICITY IN SPONTANEOUSLY HYPERTENSIVE RATS, Cancer chemotherapy and pharmacology, 35(2), 1994, pp. 93-100

Authors: KING SYP AGRA AM SHEN HSL CHI CL ADAMS DB CURRIE VE BERTINO JR PIENIASZEK HJ QUON CY
Citation: Syp. King et al., PROTEIN-BINDING OF BREQUINAR IN THE PLASMA OF HEALTHY DONORS AND CANCER-PATIENTS AND ANALYSIS OF THE RELATIONSHIP BETWEEN PROTEIN-BINDING AND PHARMACOKINETICS IN CANCER-PATIENTS, Cancer chemotherapy and pharmacology, 35(2), 1994, pp. 101-108

Authors: MITROVSKI B PRESSACCO J MANDELBAUM S ERLICHMAN C
Citation: B. Mitrovski et al., BIOCHEMICAL EFFECTS OF FOLATE-BASED INHIBITORS OF THYMIDYLATE SYNTHASE IN MGH-U1 CELLS, Cancer chemotherapy and pharmacology, 35(2), 1994, pp. 109-114

Authors: WILL P GUGER KA SCHOR NF
Citation: P. Will et al., EFFECTS OF NEOCARZINOSTATIN UPON THE DEVELOPMENT OF TUMORS FROM MURINE NEUROBLASTOMA-CELLS, Cancer chemotherapy and pharmacology, 35(2), 1994, pp. 115-120

Authors: DOLAN ME PEGG AE MOSCHEL RC VISHNUVAJJALA BR FLORA KP GREVER MR FRIEDMAN HS
Citation: Me. Dolan et al., BIODISTRIBUTION OF O-6-BENZYLGUANINE AND ITS EFFECTIVENESS AGAINST HUMAN BRAIN-TUMOR XENOGRAFTS WHEN GIVEN IN POLYETHYLENE-GLYCOL OR CREMOPHOR-EL, Cancer chemotherapy and pharmacology, 35(2), 1994, pp. 121-126

Authors: AARON RH ELION GB COLVIN OM GRAHAM M KEIR S BIGNER DD FRIEDMAN HS
Citation: Rh. Aaron et al., BUSULFAN THERAPY OF CENTRAL-NERVOUS-SYSTEM XENOGRAFTS IN ATHYMIC MICE, Cancer chemotherapy and pharmacology, 35(2), 1994, pp. 127-131

Authors: LAUTERBURG BH NGUYEN T HARTMANN B JUNKER E KUPFER A CERNY T
Citation: Bh. Lauterburg et al., DEPLETION OF TOTAL CYSTEINE, GLUTATHIONE, AND HOMOCYSTEINE IN PLASMA BY IFOSFAMIDE MESNA THERAPY, Cancer chemotherapy and pharmacology, 35(2), 1994, pp. 132-136

Authors: SHARP SY MISTRY P VALENTI MR BRYANT AP KELLAND LR
Citation: Sy. Sharp et al., SELECTIVE POTENTIATION OF PLATINUM DRUG CYTOTOXICITY IN CISPLATIN-SENSITIVE AND CISPLATIN-RESISTANT HUMAN OVARIAN-CARCINOMA CELL-LINES BY AMPHOTERICIN-B, Cancer chemotherapy and pharmacology, 35(2), 1994, pp. 137-143

Authors: SIPS JHM VANTELLINGEN O NOOIJEN WJ RODENHUIS S HUININK WWT BEIJNEN JH
Citation: Jhm. Sips et al., THE PHARMACOKINETICS OF REDUCED FOLATES AFTER INTRAPERITONEAL AND INTRAVENOUS ADMINISTRATION OF RACEMIC [6S,R]-FOLINIC ACID, Cancer chemotherapy and pharmacology, 35(2), 1994, pp. 144-148

Authors: MAENPAA J WIEBE V WURZ G KOESTER S EMSHOFF V SEYMOUR R DEGREGORIO M
Citation: J. Maenpaa et al., REDUCED TAMOXIFEN ACCUMULATION IS NOT ASSOCIATED WITH STIMULATED GROWTH IN TAMOXIFEN RESISTANCE, Cancer chemotherapy and pharmacology, 35(2), 1994, pp. 149-152

Authors: CHING LM JOSEPH WR ZHUANG L BAGULEY BC
Citation: Lm. Ching et al., INTERACTION BETWEEN ENDOTOXIN AND THE ANTITUMOR AGENT 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID IN THE INDUCTION OF TUMOR-NECROSIS-FACTOR AND HEMORRHAGIC NECROSIS OF COLON-38 TUMORS, Cancer chemotherapy and pharmacology, 35(2), 1994, pp. 153-160

Authors: RASCHKO JW AKMAN SA LEONG LA MARGOLIN KA MORGAN RJ NEWMAN E SOMLO G AHN C DOROSHOW JH
Citation: Jw. Raschko et al., PHASE-I STUDY OF 5-DAY CONTINUOUS-INFUSION FLUORODEOXYURIDINE AND HIGH-DOSE FOLINIC ACID WITH ORAL HYDROXYUREA, Cancer chemotherapy and pharmacology, 35(2), 1994, pp. 161-164

Authors: THOMAS GW MUSS HB JACKSON DV MCCULLOCH J RAMSEUR W MCFARLAND J HOEN H PAVY M HEATH R
Citation: Gw. Thomas et al., VINCRISTINE WITH HIGH-DOSE ETOPOSIDE IN ADVANCED BREAST-CANCER - A PHASE-II TRIAL OF THE PIEDMONT-ONCOLOGY-ASSOCIATION, Cancer chemotherapy and pharmacology, 35(2), 1994, pp. 165-168

Authors: RAYNAUD FI KELLAND LR WALTON MI JUDSON IR
Citation: Fi. Raynaud et al., PRECLINICAL PHARMACOLOGY OF 1069C85, A NOVEL TUBULIN BINDER, Cancer chemotherapy and pharmacology, 35(2), 1994, pp. 169-173

Authors: STOGER H BAUERNHOFER T SCHMID M PLONER F MOSER R DERSTVENSCHEG E STEINDORFER P WILDERSTRUSCHNIG M KUSS I SAMONIGG H
Citation: H. Stoger et al., A PHASE-I II STUDY OF 4'-O-TETRAHYDROPYRANYL-DOXORUBICIN, 5-FLUOROURACIL, AND HIGH-DOSE LEUCOVORIN AS FIRST-LINE THERAPY IN ADVANCED BREAST-CANCER PATIENTS/, Cancer chemotherapy and pharmacology, 35(2), 1994, pp. 174-178

Authors: VANWARMERDAM LJC RODENHUIS S VANTELLINGEN O MAES RAA BEIJNEN JH
Citation: Ljc. Vanwarmerdam et al., VALIDATION OF A LIMITED SAMPLING MODEL FOR CARBOPLATIN IN A HIGH-DOSECHEMOTHERAPY COMBINATION, Cancer chemotherapy and pharmacology, 35(2), 1994, pp. 179-181

Authors: VOLPE DA DU DL GRIESHABER CK MURPHY MJ
Citation: Da. Volpe et al., IN-VITRO CHARACTERIZATION OF THE MYELOTOXICITY OF CYCLOPENTENYL CYTOSINE (VOL 34, PG 103, 1994), Cancer chemotherapy and pharmacology, 35(2), 1994, pp. 182-182

Authors: PINZANI V BRESSOLLE F HAUG IJ GALTIER M BLAYAC JP BALMES P
Citation: V. Pinzani et al., CISPLATIN-INDUCED RENAL TOXICITY AND TOXICITY-MODULATING STRATEGIES -A REVIEW, Cancer chemotherapy and pharmacology, 35(1), 1994, pp. 1-9

Authors: ONO M TANAKA N ORITA K
Citation: M. Ono et al., POSITIVE INTERACTIONS BETWEEN HUMAN INTERFERON AND CEPHARANTHIN AGAINST HUMAN CANCER-CELLS IN-VITRO AND IN-VIVO, Cancer chemotherapy and pharmacology, 35(1), 1994, pp. 10-16

Authors: LANKS KW GAO JP SHARMA T
Citation: Kw. Lanks et al., PHOTODYNAMIC ENHANCEMENT OF DOXORUBICIN CYTOTOXICITY, Cancer chemotherapy and pharmacology, 35(1), 1994, pp. 17-20

Authors: WADLER S SCHWARTZ EL
Citation: S. Wadler et El. Schwartz, BIOLOGIC AGENTS AS BIOCHEMICAL MODULATORS - PHARMACOLOGICAL BASIS FORTHE INTERACTION OF CYTOTOXIC CHEMOTHERAPEUTIC DRUGS AND INTERFERON, Cancer chemotherapy and pharmacology, 35(1), 1994, pp. 21-30

Authors: CROWELL PL ELSON CE BAILEY HH ELEGBEDE A HAAG JD GOULD MN
Citation: Pl. Crowell et al., HUMAN METABOLISM OF THE EXPERIMENTAL CANCER THERAPEUTIC AGENT D-LIMONENE, Cancer chemotherapy and pharmacology, 35(1), 1994, pp. 31-37

Authors: YOSHIDA M KHOKHAR AR ZHANG YP THAI G SIDDIK ZH
Citation: M. Yoshida et al., KINETICS OF TISSUE DISPOSITION OF CIS-AMMINE CYCLOHEXYLAMINE-DICHLOROPLATINUM(II) AND CISPLATIN IN MICE BEARING FSAIIC TUMORS, Cancer chemotherapy and pharmacology, 35(1), 1994, pp. 38-44

Authors: JAKOBSEN P SORENSEN B BASTHOLT L MIRZA MR GJEDDE SB MOURIDSEN HT ROSE C
Citation: P. Jakobsen et al., THE PHARMACOKINETICS OF HIGH-DOSE EPIRUBICIN AND OF THE CARDIOPROTECTOR ADR-529 GIVEN TOGETHER WITH CYCLOPHOSPHAMIDE, 5-FLUOROURACIL, AND TAMOXIFEN IN METASTATIC BREAST-CANCER PATIENTS, Cancer chemotherapy and pharmacology, 35(1), 1994, pp. 45-52

Authors: LEBOT MA KERNALEGUEN D ROBERT J BERLION M RICHE C
Citation: Ma. Lebot et al., MODULATION OF ANTHRACYCLINE ACCUMULATION AND METABOLISM IN RAT HEPATOCYTES IN CULTURE BY 3 REVERTANTS OF MULTIDRUG-RESISTANCE, Cancer chemotherapy and pharmacology, 35(1), 1994, pp. 53-58
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>